Mongolia vs Singapore: Proportion of isolates with decreased susceptibility or resistance
Mongolia
0.7752
in 2018
Singapore
2.2
in 2020
Mongolia rank
9th
Singapore rank
6th
Proportion of isolates with decreased susceptibility or resistance over time
- Mongolia
- Singapore
How they compare
Singapore currently reports 2.2 against 0.7752 in Mongolia, a difference of 1.42.
That makes Singapore's figure about 2.8 times Mongolia's.
The two have swapped places 3 times across 6 shared years of data; in 2009 it was Mongolia ahead.
Mongolia ranks 9th and Singapore ranks 6th of 52 countries.
Mongolia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mongolia | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 19.13 | 1.25 | 17.88 | Mongolia |
| 2010s | 11.33 | 3 | 8.33 | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Mongolia or Singapore?
- Singapore, at 2.2 against 0.7752 in Mongolia as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Mongolia and Singapore?
- 1.42, with Singapore ahead.
- How many years of comparable data are there for Mongolia and Singapore?
- 6 years are reported by both, from 2009 to 2018.
- How do Mongolia and Singapore rank globally for proportion of isolates with decreased susceptibility or resistance?
- Mongolia ranks 9th and Singapore ranks 6th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.